Analyst	Recommendation	Action	Price target	Projected	Date
Mark Hughes Truist Financial	Buy	Reiterated	$235.00	+27.5%	10/01/2026
Adam Klauber William Blair	Buy	Maintained	-	-	09/15/2026
Ryan Tunis Cantor Fitzgerald	Buy	Maintained	$225.00	+22.1%	08/06/2026
Terry Tillman Truist Financial	Buy	Maintained	$235.00	+27.5%	08/07/2026
Matthew Carletti Citizens JMP	Buy	Maintained	$265.00	+43.8%	08/07/2026
Michael Phillips CFA Oppenheimer	Hold	Downgraded	$190.00	+3.1%	11/13/2025

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	216.35M	246.24M	242.88M	246.65M
Cost of goods sold	97.80M	84.86M	97.37M	103.42M
Cost of revenue	97.80M	84.86M	97.37M	103.42M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	20.95M	10.41M	22.35M	23.95M
Operating expense	26.93M	1.14B	29.20M	31.17M
Total operating expenses	124.73M	1.23B	126.58M	134.60M
Operating income	91.62M	-978.87M	116.31M	112.06M
Other non operating income	-	-	-	-
EBT including unusual items	90.60M	144.00M	115.38M	110.97M
EBT excluding unusual items	90.60M	-979.88M	115.38M	110.97M
Income tax expense	22.71M	36.00M	30.34M	28.07M
Effective tax rate	25.07%	25.00%	26.30%	25.30%
Other operating expenses	5.98M	1.13B	6.85M	7.23M
Net income	65.51M	97.65M	73.41M	73.80M
Net profit margin	30.28%	39.66%	30.22%	29.92%
Earnings per share	4.90	7.25	5.45	5.60
Interest and investment income	-	-	-	-
Interest expense	-1.02M	-1.01M	-923.00K	-1.08M
Net interest expenses	-1.02M	-1.01M	-923.00K	-1.08M
Depreciation and amortization charges	-	-	-	-
EBITDA	93.94M	-976.65M	118.55M	114.10M
Gain or loss from assets sale	-	-	-354.00K	-

Ask anything